Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Cara De Galan
Profile
Projects
Publications
Activities
Awards & Distinctions
11
Results
2024
Safety and effectiveness of vedolizumab and ustekinumab in elderly patients with inflammatory bowel disease : a real-life multicentric cohort study
Tom Holvoet
Marie Truyens
Cara De Galan
Harald Peeters
Francisco Mesonero Gismero
Ainara Elorza
Paola Torres
Liv Vandermeulen
Aranzazu Jauregui-Amezaga
Rocio Ferreiro-Iglesias
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL MEDICINE
2024
2022
New insights in the use of vedolizumab in inflammatory bowel disease
Cara De Galan
Debby Laukens
Pieter Hindryckx
Dissertation
2022
Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study
Cara De Galan
Bryan Gonzales
Sophie Van Welden
Simon Tavernier
Triana Lobatón Ortega
Wouter Van Moerkercke
Beatrijs Strubbe
Harald Peeters
Elisabeth Macken
Martine De Vos
et al.
A1
Journal Article
in
CLINICAL AND TRANSLATIONAL MEDICINE
2022
The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentre cohort study
Cara De Galan
Marie Truyens
Harald Peeters
Francisco Mesonero Gismero
Ainara Elorza
Paola Torres
Liv Vandermeulen
Aranzazu Jauregui Amezaga
Rocio Ferreiro- Iglesias
Tom Holvoet
et al.
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2022
2021
Early prediction of response to vedolizumab in patients with active inflammatory bowel disease : a prospective real-life multicentre cohort study
Cara De Galan
Gerard Bryan Gonzales
Sophie Van Welden
Simon Tavernier
Triana Lobatón Ortega
Wouter Van Moerkercke
Beatrijs Strubbe
Harald Peeters
Elisabeth Macken
Martine De Vos
et al.
C3
Conference
2021
Long-term environmental hypoxia does not impact experimental Crohn's like ileitis
Cara De Galan
Sophie Van Welden
Triana Lobatón Ortega
Pieter Hindryckx
Martine De Vos
Debby Laukens
C3
Conference
2021
Long-term environmental hypoxia exposure and haematopoietic prolyl hydroxylase-1 deletion do not impact experimental Crohn's like ileitis
Cara De Galan
Martine De Vos
Pieter Hindryckx
Debby Laukens
Sophie Van Welden
A1
Journal Article
in
BIOLOGY-BASEL
2021
Safety of vedolizumab and ustekinumab in elderly IBD patients : a real-life multicentric cohort study
Cara De Galan
Marie Truyens
Harald Peeters
Francisco Mesonero Gismero
Ainara Elorza
Paola Torres
Liv Vandermeulen
Aranzazu Jauregui Amezaga
Rocio Ferreiro-Iglesias
Tom Holvoet
et al.
C3
Conference
2021
The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients : a real-life multicentric cohort study
Marie Truyens
Cara De Galan
H Peeters
F Mesonero Gismero
A Elorza
P Torres
L Vandermeulen
A Jauregui Amezaga
R Ferreiro-Iglesias
T Holvoet
et al.
C3
Conference
2021
2020
Integrin expression changes on the T cells subsets influence the response to vedolizumab in inflammatory bowel disease patients
Cara De Galan
Sophie Van Welden
Simon Bos
Simon Tavernier
Triana Lobatón Ortega
Bryan Gonzales
Wouter Van Moerkercke
Beatrijs Strubbe
Harald Peeters
Elisabeth Macken
et al.
C3
Conference
2020
2019
Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients
Cara De Galan
Sophie Van Welden
Simon Bos
Simon Tavernier
Triana Lobatón Ortega
Bryan Gonzales
Wouter Van Moerkercke
Beatrijs Strubbe
Harald Peeters
Elisabeth Macken
et al.
C3
Conference
2019